Investments Investment Vehicles 

Leveraging a Unique Combination 

GlenRock's unique combination of private equity, multidisciplinary in-house expertise and unmatched access to quality dealflow enabled GlenRock to initiate a variety of Investment Vehicles with diversified focus. 

Mivtach Shamir (TASE:MISH)

Is a publicly-traded company, headed and controlled by Mr. Meir Shamir. The company focuses on private equity investments, with the aim of leading them to increasing value for shareholders.

Within the Mivtach Shamir portfolio, were prominent companies like Tnuva (sold to Bright Food), Lipman (sold to Verifone), Gilat Satellite, Menif, Energy, Real Estate (in Israel and abroad) investments and Hi Tech Companies. 

Shavit Capital Fund (I-V) 

Is a fund aimed to create high returns for investors by buying and investing in equity-related securities mainly in later stage/mezzanine rounds, where plans for an IPO or any other form of exit are reasonably demonstrated, and in IPOs and secondary/PIPE offerings. 

The funds' most notable investments (and exits) were in Kamada, Superderivatives, Brainsway, Foamix, Rewalk, Intech Pharma. 

Latest News (03/2021):  The five funds raised $200M+ are invested in Mapi Pharma, Polus, Gamidacell, BioCancell, AlphaTau, Syqe Trax, Ayala Pharma and Polypid.



Altris is one of Israel's leading Proprietary Trading firm. It manages a multi-strategy portfolio across several asset classes such as FX, Corporate and Government Bonds, Equity and Derivative products.

A vast  part of the team is dedicated to research and risk management with strong emphasis on diversification, technological infrastructure for best execution, quantitative as well as fundamental research. 

Altris has an outstanding track record and low volatility of returns in all markets

Infinity Israel-China

In March 2010, Infinity Israel-China Fund announced the establishment of six new joint private equity funds throughout China bringing total funds raised by the Fund to $420M. Infinity Israel-China Fund utilized Infinity’s experience and partnerships in China and Infinity’s access to proven Israeli technologies to add value to the fund’s portfolio companies in both China and Israel.


This was achieved by collaborating with the fund's Sponsors; GlenRock Israel and Clal Industries and Investments, partnered with Suzhou Industrial Park Science & Technology Development and China-Singapore Suzhou Industrial Park Ventures Co. The fund was primarily focused on accelerating the growth of its portfolio companies by helping them meet the demand for technology based products in China. The fund achieved a successful exit with the sale of Digital China. Shellcase, DCITS and E.T. Xin, were listed on the Shanghai stock exchange.


The fund concluded its investment period and is in the final stages of realizing its portfolio.

Rainbow Medical Innovation

A private investment company, which aims to seed and grow companies, mostly invented by the serial entrepreneur Yossi Gross, that develop breakthrough medical device-based therapeutic platforms addressing significant unmet market need and leads them to becoming high value companies.


Rainbow Medical is committed to generating returns from its portfolio of cutting edge medical device technologies in a diverse range of medical fields. Among Rainbow's investors are major players in the industry as Medtronic and Abbott and the Kirsh Group. Rainbow assists the portfolio companies from seeding through obtainment of European CE Mark and an FDA. leading portfolio companies are Vascular Dynamics, Bluewind, Nano Retina, Chronisense and Enopace, some have entered into First in Man clinical studies. 

Latest News (03/2021): Rainbow invested more than $200M and lately raised $80M from insiders, led by the Kirsh Group. Rainbow is focused on leading portfolio companies.

Infinity Innonation Medical Fund


A limited partnership for investments in medical research and development companies based in Israel. The fund will invests in medical R&D companies with an emphasis on digital health technologies and being a bridge to China for these technologies.